Goldman Sachs
CVRX icon

Goldman Sachs’s CVRx CVRX Stock Holding History

Goldman Sachs’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.9M Buy
201,011
+23,413
+13% +$171K ﹤0.01% 4586
2025
Q4 		$1.26M Sell
177,598
-24,459
-12% -$223K ﹤0.01% 4952
2025
Q3 		$1.63M Buy
202,057
+122,201
+153% +$919K ﹤0.01% 4656
2025
Q2 		$470K Sell
79,856
-47,050
-37% -$325K ﹤0.01% 5198
2025
Q1 		$1.55M Sell
126,906
-19,645
-13% -$277K ﹤0.01% 4354
2024
Q4 		$1.86M Buy
146,551
+34,214
+30% +$422K ﹤0.01% 4355
2024
Q3 		$990K Buy
112,337
+66,857
+147% +$608K ﹤0.01% 4640
2024
Q2 		$545K Sell
45,480
-31,210
-41% -$359K ﹤0.01% 4784
2024
Q1 		$1.4M Buy
76,690
+55,987
+270% +$1.33M ﹤0.01% 4110
2023
Q4 		$651K Buy
+20,703
New +$388K ﹤0.01% 4610
2023
Q3 		– Sell
-10,917
Closed -$169K – 5594
2023
Q2 		$169K Sell
10,917
-33,302
-75% -$406K ﹤0.01% 5237
2023
Q1 		$412K Buy
+44,219
New +$585K ﹤0.01% 4937
2022
Q1 		– Sell
-12,063
Closed -$148K – 6614
2021
Q4 		$148K Buy
+12,063
New +$175K ﹤0.01% 6008
2021
Q3 		– Sell
-119,066
Closed -$3.33M – 6271
2021
Q2 		$3.33M Buy
+119,066
New +$3.33M ﹤0.01% 3717

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GP
GSK plc London $599M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's CVRX Position: Q1 2026 in Review

Goldman Sachs increased its CVRx (CVRX) stake by 13% in Q1 2026, buying an estimated $171K and bringing the position to 201,011 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #4586.

Goldman Sachs first reported a position in CVRX in Q2 2021 and has held it in 14 quarters since. The position peaked at $3.33M in Q2 2021. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

  • Goldman Sachs held 201,011 shares of CVRx worth $1.9M as of Q1 2026.
  • Goldman Sachs bought 23,413 CVRx shares in Q1 2026, an estimated $171K.
  • CVRx made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4586 holding.
  • Goldman Sachs first reported a position in CVRx in Q2 2021 and has held it in 14 quarters since.
  • Goldman Sachs's CVRx position peaked at $3.33M in Q2 2021.
  • 99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.